ImmuPharma shares rocket 200% on autoimmune breakthrough ImmuPharma PLC (AIM:IMM) shares rocketed on Thursday following groundbreaking findings from its preclinical research focused on autoimmune diseases. The...…
AIM movers: Aquis-quoted Incanthera’s revenue projections increases the value of Immupharma stake Immpharma (LON: IMM) owns 10.8% of Aquis-quoted Incanthera (LON: INC), which has published an update on its distribution deal with…